The treatments of the future may arise from a long-stigmatized class of drugs. The first modern antidepressants were originally tuberculosis medications, created from leftover World War II rocket fuel. In 2019, the Federal Drug Administration approved Spravato for depression, a chemical that was originally a veterinary anesthetic and later used recreationally as a club drug. Why shouldn’t […] Read more…
Amanda Itzkoff MD and NYC Psychiatry are pleased to announce they’re now accepting new patients for intranasal esketamine (SPRAVATO™) treatment. What is SPRAVATO™ ? SPRAVATO™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. SPRAVATO™ is not for use as a medicine to prevent or relieve pain […] Read more…
2019 is off to a great start! New research and developments in psychiatric care help pave the way to enhanced treatment options for common mental illnesses. These advancements offer life-changing possibilities to those who need something more than standard protocol. Here’s a quick recap… Esketamine’s FDA Approval The FDA’s approval of esketamine (Spravato) nasal spray […] Read more…
How do you help someone lost in darkness of deep depression? The loneliness, the emptiness-the hopelessness? In the field of psychiatry, our first-line treatment usually consists of psychotherapy and medication. Most patients receive benefits and maintain improvement from these treatments. But, for the one-third of patients who are failed by traditional protocol, interventional psychiatry […] Read more…
Research is Recognizing More Uses for Ketamine Treatment In a 2017 paper “Considerations on the Off-Label Use of Ketamine as a Treatment for Mood Disorders” the authors Samuel T. Wilkinson, MD and Gerard Anancora, MD, PhD note that an increasing number of small clinical trials is proving the efficacy of the drug Ketamine for helping […] Read more…
Two New Studies Help Shed Light on How Ketamine Works to Counteract Depression More and more press releases are calling Ketamine’s antidepressant effects “the biggest thing to happen in psychiatry in 50 years”. The reason for the title is the remarkable speed with which ketamine improves symptoms of depression: in as little as 30 minutes […] Read more…
New Studies Affirm Ketamine as an Effective Treatment for Depression In a post from the Fall of last year, I discussed how Ketamine, a substance discovered in 1962 and historically used for anaesthesia, has been gaining attention as a solution for treating depression in patients who have proven to be resistant to other forms of […] Read more…
The Results We Have Seen from Ketamine Therapy at the Practice If you have followed my blog recently, you may have come across some of my observations about Ketamine, a drug used as a sedative (and sometimes abused as a club drug known as “Special K”,) but that is now being used to help patients with […] Read more…
Ketamine & PTSD – What Does the Research Show Post-Traumatic Stress Disorder (PTSD) is a mental illness that involves individuals who have been subjected to some variety of trauma either as a result of a single incident or due to prolonged exposure. Individuals with PTSD feel overwhelming and debilitating fear and anxiety and often feel […] Read more…
There’s Hope for Treatment-Resistant Depression Many patients with depression come to me who have had little or no success treating their depression with medication – these patients are typically referred to as “treatment-resistant.” The drug ketamine has been in the spotlight recently as a drug that can treat severe depression that traditional anti-depressants has been […] Read more…